The tumour suppressor CYLD is a deubiquitinase previously shown to inhibit NF-° B, MAP kinase and Wnt signalling. However, the tumour suppressing mechanisms of CYLD remain poorly understood. Here we show that loss of CYLD catalytic activity causes impaired DNA damage-induced p53 stabilization and activation in epithelial cells and sensitizes mice to chemical carcinogen-induced intestinal and skin tumorigenesis. Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress. Ubiquitin chain-restriction analysis provides evidence that CYLD removes K48 ubiquitin chains from p53 indirectly by cleaving K63 linkages, suggesting that p53 is decorated with complex K48/K63 chains. Moreover, CYLD deficiency also diminishes CEP-1/p53-dependent DNA damage-induced germ cell apoptosis in the nematode Caenorhabditis elegans. Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activation and suggest that regulation of p53 responses to genotoxic stress contributes to the tumour suppressor function of CYLD.
CITATION STYLE
Fernández-Majada, V., Welz, P. S., Ermolaeva, M. A., Schell, M., Adam, A., Dietlein, F., … Pasparakis, M. (2016). The tumour suppressor CYLD regulates the p53 DNA damage response. Nature Communications, 7. https://doi.org/10.1038/ncomms12508
Mendeley helps you to discover research relevant for your work.